|
|
 |
INDIA-JAPAN-PHARMACEUTICAL-MERGER-DAIICHI-RANBAXY-SUN-FILES
(FILES) In this file picture taken on April 7, 2014, Indian employees of the country's third-biggest drugs company Sun Pharma walk outside its research and development centre in Mumbai. On the surface, Sun Pharma's 3.2-billion USD purchase of Indian generics rival Ranbaxy, which is in deep trouble with US regulators over safety lapses, may not look like a great deal. But Sun Pharmaceutical Industries' shares rocketed on last week's announcement it was buying Ranbaxy from Japanese drugmaker Daiichi Sankyo, which struggled unsuccessfully to resolve the Indian company's regulatory woes after its 2008 4.6-billion USD acquisition. AFP PHOTO / FILES / INDRANIL MUKHERJEE
|
|
|
|
Detalii fotografie |
| Loc: |
|
Mumbai, INDIA |
|
| Sursa: |
|
AFP / Mediafax Foto |
|
| Fotograf: |
|
Indranil MUKHERJEE |
|
| Data: |
|
13 Aprilie 2014 |
|
| Dimensiuni: |
|
4256 x 2832 (960.86 KB) |
|
|
|
|
|
|